CFO
EXEL icon

CVA Family Office’s Exelixis EXEL Stock Holding History

CVA Family Office’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.8K Buy
364
+94
+35% +$4.58K ﹤0.01% 818
2026
Q1 		$11.6K Buy
270
+247
+1,074% +$10.6K ﹤0.01% 942
2025
Q4 		$1.01K Hold
23
– – ﹤0.01% 1100
2025
Q3 		$950 Hold
23
– – ﹤0.01% 1135
2025
Q2 		$1.01K Hold
23
– – ﹤0.01% 1095
2025
Q1 		$849 Hold
23
– – ﹤0.01% 1144
2024
Q4 		$766 Hold
23
– – ﹤0.01% 1138
2024
Q3 		$597 Hold
23
– – ﹤0.01% 1160
2024
Q2 		$517 Buy
+23
New +$510 ﹤0.01% 1194

Other funds holding EXEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CVA Family Office's EXEL Position: Q2 2026 in Review

CVA Family Office increased its Exelixis (EXEL) stake by 35% in Q2 2026, buying an estimated $4.58K and bringing the position to 364 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #818.

CVA Family Office first reported a position in EXEL in Q2 2024 and has held it in 9 quarters since. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • CVA Family Office held 364 shares of Exelixis worth $19.8K as of Q2 2026.
  • CVA Family Office bought 94 Exelixis shares in Q2 2026, an estimated $4.58K.
  • Exelixis made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #818 holding.
  • CVA Family Office first reported a position in Exelixis in Q2 2024 and has held it in 9 quarters since.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.